BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Leukemia AND NONO, Q15233, 4841, ENSG00000147140, NRB54, P54NRB, NMT55, P54 AND Diagnosis
3 results:

  • 1. Analysis of RBP expression and binding sites identifies PTBP1 as a regulator of CD19 expression in B-ALL.
    Ziegler N; Cortés-López M; Alt F; Sprang M; Ustjanzew A; Lehmann N; El Malki K; Wingerter A; Russo A; Beck O; Attig S; Roth L; König J; Paret C; Faber J
    Oncoimmunology; 2023; 12(1):2184143. PubMed ID: 36875548
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Venous thromboembolism incidence and risk factors in adults with acute lymphoblastic leukemia treated with and without pegylated E. coli asparaginase-containing regimens.
    Kashanian SM; Holtzman NG; Patzke CL; Cornu J; Duffy A; Koka M; Niyongere S; Duong VH; Baer MR; Apata J; Kamangar F; Emadi A
    Cancer Chemother Pharmacol; 2021 Jun; 87(6):817-826. PubMed ID: 33677674
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Impact of baseline clinical and laboratory features on the risk of thrombosis in children with acute lymphoblastic leukemia: A prospective evaluation.
    Athale UH; Mizrahi T; Laverdière C; Nayiager T; Delva YL; Foster G; Thabane L; David M; Leclerc JM; Chan AKC
    Pediatr Blood Cancer; 2018 May; 65(5):e26938. PubMed ID: 29334169
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.